Notes to Unaudited Pro Forma Condensed Consolidated Combined Statement of Operations
1. Basis of Presentation
The unaudited pro forma condensed consolidated combined statement of operations has been prepared in accordance with Article 11 using assumptions set forth in the notes herein. The Company has elected not to present Management Adjustments and has only presented Transaction Accounting Adjustments in the unaudited pro forma condensed consolidated combined statement of operations.
On July 1, 2022, the Merger was completed, and the Company issued 22,671,871 shares of common stock and paid $245.4 million of cash to Whiting stockholders. Under the terms of the Merger Agreement, each holder of common stock, par value of $0.001 per share, of Whiting received 0.5774 shares of common stock, par value $0.01 per share, of the Company and $6.25 in cash in exchange for each share of Whiting common stock owned. Also in connection with the Merger, on June 16, 2022, the Board of Directors of Oasis declared the Special Dividend that was paid on July 8, 2022 to stockholders of record as of June 29, 2022. The Merger was accounted for under the acquisition method of accounting in accordance with ASC 805, with Oasis treated as the accounting acquirer. Under ASC 805, the assets and liabilities of Whiting have been recorded at their respective fair values as of the acquisition date of July 1, 2022. As provided under ASC 805, the purchase price allocation may be subject to change for up to one year after July 1, 2022. Accordingly, the pro forma adjustments are preliminary, have been made solely for the purpose of providing pro forma financial information and are subject to revision based on a final determination of fair value as of the closing date of the Merger. Differences between these preliminary estimates and the final allocation of the consideration to be paid may have a material impact on the accompanying unaudited pro forma condensed consolidated combined statement of operations.
On February 1, 2022, OMP and OMP GP completed the OMP Merger with Crestwood. At the closing of the OMP Merger, the Company sold to Crestwood its entire ownership of OMP common units and all of the limited liability company interests of OMP GP in exchange for $160.0 million in cash and 20,985,668 common units of Crestwood, representing approximately 21% of Crestwood’s issued and outstanding common units as of February 1, 2022. In addition, the Company appointed two directors to the Board of Directors of Crestwood GP in connection with the execution of a director nomination agreement at the closing of the OMP Merger.
At closing on February 1, 2022, the Company accounted for the derecognition of OMP from its consolidated financial statements in accordance with FASB ASC 810-10, Consolidation, and derecognized the assets, liabilities and equity of OMP, including non-controlling interests. Upon deconsolidation, the Company recognized a gain that was recorded to income from discontinued operations, net of income tax. In accordance with Article 11, the unaudited pro forma condensed consolidated combined statement of operations is presented through income from continuing operations; accordingly, the Transaction Accounting Adjustments presented herein do not include the discontinued operations of OMP nor the effects of the gain on sale within the pro forma unaudited condensed consolidated combined statement of operations.
The Company elected the fair value option under ASC 825-10 to account for its investment in Crestwood. In accordance with ASC 825-10, the Company measures the carrying amount of its investment in Crestwood at fair value each reporting period with changes in fair value and distributions received from Crestwood recorded to income from investment in unconsolidated affiliate on the consolidated statement of operations.
The unaudited pro forma condensed consolidated combined statement of operations for the year ended December 31, 2022 was prepared as if the Merger and the OMP Merger had occurred on January 1, 2022. In addition, the OMP Merger represented a strategic shift for the Company and qualified as a discontinued operation in accordance with ASC 205-20. Accordingly, the results of operations of OMP were classified as discontinued operations in the Company’s historical audited consolidated statement of operations for the year ended December 31, 2022. In accordance with Article 11, as the discontinued operation was included in the historical income statement, the unaudited pro forma condensed consolidated combined statement of operations is presented through income from continuing operations.
The unaudited pro forma condensed consolidated combined statement of operations has been derived from the historical consolidated financial statements of the Company and Whiting. As the Merger was consummated on July 1, 2022, the Company’s historical audited consolidated statement of operations for the year ended December 31, 2022 includes the results of legacy Oasis for the period from January 1, 2022 through June 30, 2022 and the consolidated results of Chord for the period from July 1, 2022 through December 31, 2022. The unaudited pro forma condensed consolidated combined balance sheet and supplemental pro forma disclosures about oil and gas producing activities as of December 31, 2022, are not presented, as the Merger and OMP Merger had been completed as of that date. Accordingly, the Merger and OMP Merger are reflected in the consolidated balance sheet and the supplemental disclosures about oil and gas producing activities as of December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 28, 2023.
The unaudited pro forma condensed consolidated combined statement of operations and underlying pro forma adjustments are based upon currently available information and include certain estimates and assumptions made by management; accordingly, actual results could differ materially from the pro forma information. Management believes the assumptions provide a reasonable and supportable basis for presenting the estimated significant effects of the transactions described above. The unaudited pro forma condensed consolidated combined statement of operations is provided for illustrative purposes only and may or may not provide an indication of results in the future.